| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 2 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 2 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 2 |
| 3 | DOXORUBICIN | 2 |
| 4 | ETOPOSIDE | 2 |
| 5 | EVEROLIMUS | 2 |
| 6 | EVEROLIMUS TABLETS | 2 |
| 7 | FUROSEMIDE | 2 |
| 8 | GLYCEROL PHENYLBUTYRATE | 2 |
| 9 | PANCRELIPASE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GLYCEROL PHENYLBUTYRATE | 2 | 0.0014 |
| 1 | TAZEMETOSTAT | 1 | 0.0006 |
| 2 | SELUMETINIB | 1 | 0.0006 |
| 3 | AFATINIB | 1 | 0.0002 |
| 4 | TEDUGLUTIDE | 2 | 0.0001 |
| 5 | EVEROLIMUS TABLETS | 2 | 0.0001 |
| 6 | DASATINIB | 1 | 0.0001 |
| 7 | REGORAFENIB | 1 | 0.0001 |
| 8 | TRAMETINIB | 2 | 0.0001 |
| 9 | SIROLIMUS | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | GLP-2 Analog [EPC] | 2 | 0.0001 |
| 1 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Topoisomerase Inhibitor [EPC] | 2 | 0.0000 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 4 | Arteriolar Vasodilator [EPC] | 1 | 0.0000 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 6 | Alkylating Drug [EPC] | 2 | 0.0000 |
| 7 | Histamine-2 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Phosphodiesterase 5 Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Serotonin-3 Receptor Antagonist [EPC] | 1 | 0.0000 |